Singapore -
English -
HSA (Health Sciences Authority)
feg textiltechnik dynamesh-lichtenstein
medquest marketing pte ltd - general hospital - dynamesh®-lichtenstein serves to support the tissue and stabilise the fascial structures of the inguinal region. dynamesh®-lichtenstein was specially developed for the conventional repair of inguinal hernias according to lichtenstein. dynamesh®-lichtenstein must not be used in intraperitoneal onlay mesh technique (ipom technique).
Ireland -
English -
HPRA (Health Products Regulatory Authority)
bendamustine hcl 100 mg powder for concentrate for solution for infusion
fresenius kabi deutschland gmbh - bendamustine hydrochloride - powder for concentrate for solution for infusion - 100 milligram(s) - nitrogen mustard analogues; bendamustine
Ireland -
English -
HPRA (Health Products Regulatory Authority)
bendamustine hcl 25 mg powder for concentrate for solution for infusion
fresenius kabi deutschland gmbh - bendamustine hydrochloride - powder for concentrate for solution for infusion - 25 milligram(s) - nitrogen mustard analogues; bendamustine
Germany -
English -
BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)
predni 10 mg lichtenstein n
Germany -
English -
BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)
predni 25 mg lichtenstein n
Germany -
English -
BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)
ibuflam 400mg lichtenstein
Germany -
English -
BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)
ibuflam 600mg lichtenstein
Ireland -
English -
HPRA (Health Products Regulatory Authority)
lifsar pulmojet 50/500 microgram powder for inhalation
sanofi-aventis ireland limited t/a sanofi - salmeterol xinafoate, fluticasone propionate - powder for inhalation - 50/500 microgram - adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics - adrenergics, inhalants; adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics. - lifsar pulmojet is indicated for the symptomatic treatment of adults with chronic obstructive pulmonary disease (copd) with a fev1 < 60% predicted normal (pre-bronchodilator) and a history of repeated exacerbations and who have significant symptoms despite regular bronchodilator therapy.
Malta -
English -
Medicines Authority
bendamustine hydrochloride 2.5mg/ml powder for concentrate for solution for infusion (25mg vial)
fresenius kabi italia s.r.l via camagre 41, 37063 isola della scala (vr) , italy - powder for concentrate for solution for infusion - bendamustine hydrochloride 2.5 mg/ml - antineoplastic agents
Malta -
English -
Medicines Authority
bendamustine hydrochloride 2.5mg/ml powder for concentrate for solution for infusion(100mg vial)
fresenius kabi italia s.r.l via camagre 41, 37063 isola della scala (vr) , italy - powder for concentrate for solution for infusion - bendamustine hydrochloride 2.5 mg/ml - antineoplastic agents